Alexander, Ryan G. http://orcid.org/0009-0007-8238-0439
Ravi, Karthik
Collins, Margaret H.
Lavey, Crystal J.
Snyder, Diana L.
Lennon, Ryan J.
Kassmeyer, Blake A.
Katzka, David A.
Alexander, Jeffrey A.
Funding for this research was provided by:
Aleta and Michael Belletete
Article History
Received: 20 April 2023
Accepted: 29 June 2023
First Online: 11 July 2023
Declarations
:
: Jeffrey Alexander has financial interest in Meritage Pharmacia, consulting agreement with Lucid Diagnostics, and research assistance with Regeneron, Ellodi, Arena, and Cellgene pharmaceuticals. Dr Katzka has received research funding from Shire and Takeda and is a consultant for Regeneron and Takeda. Margaret H. Collins is a consultant for Allakos, Arena Pharmaceuticals/Pfizer, AstraZeneca, Calypso Biotech, EsoCap Biotech, GlaxoSmithKline, Receptos/Celgene/BMS, Regeneron Pharmaceuticals, Robarts Clinical Trials Inc./Alimentiv, Inc. and Shire, a Takeda company.
: All authors approved the final version of the manuscript.